Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

3:00 PM - 3:10 PM PT

103 - An Initial Report of Memory Avoidance Whole Brain Radiotherapy to Treat Brain Metastases: A Prospective Phase 2 Trial
Speaker: Palmer, Joshua, MD - The James Cancer Hospital & Solove Research Institute, Columbus, OH
3:00 PM - 3:10 PM PT

110 - IMPARC: A Prospective Trial of Stereotactic Proton Reirradiation for Locoregionally Recurrent Rectal Cancer
Speaker: Dalwadi, Poonam, MD, BS - Washington University/B-JH/SLCH Consortium, St. Louis, MO
3:00 PM - 3:10 PM PT

117 - Outcomes Following Radiation Therapy and Radical Prostatectomy in Patients with High Risk Prostate Cancer in a Similar Access System
Speaker: Kumar, Abhishek, MD, MAS - The Oncology Institute of Hope and Innovation, Cerritos, CA
3:00 PM - 3:10 PM PT

130 - High-Dimensional Immunophenotyping of Patients with Localized Non-Small Cell Lung Cancer (NSCLC) Reveals Distinct Immune Cell Subsets Predictive of Disease-Free Survival (DFS) in AFT-16 and LCMC3 Phase II Immunotherapy Clinical Trials
Speaker: Eustace, Nicholas, MD, PhD - City of Hope National Medical Center, Duarte, CA
3:00 PM - 3:10 PM PT

137 - Exploiting Dependencies Created By KEAP1/NFE2L2 Mutations in NSCLC to Overcome Radiation Resistance
Speaker: Mai, Wilson, MD, PhD - Stanford University Cancer Center, Stanford, CA
3:05 PM - 3:12 PM PT

126 - A Real-World Comparison of Moderated Hypofractionated Radiotherapy and Conventional Fractionated Radiotherapy in Cervical Cancer
Speaker: Zeng, Zheng, MD - Peking Union Medical College Hospital, Beijing, Beijing
3:10 PM - 3:20 PM PT

104 - Deep Learning-Based Personalized Blood Dosimetry (OncoBlood) for Circulating Blood Cell Exposure Predicts Radiation-Induced Severe Lymphopenia and Survival Outcomes in Craniospinal Irradiation
Speaker: Seo, Sang Hoon, MD, PhD Candidate - Oncosoft, Seoul, SEO
3:10 PM - 3:20 PM PT

111 - Perioperative Chemotherapy Duration Affects the Survival of Locally Advanced Rectal Cancer: A Post-Hoc Analysis of a Multicenter Randomized, Phase III Trial
Speaker: Xu, Tongzhen, MD - Chinese Academy of Medical Science, Bejing, Beijing
3:10 PM - 3:20 PM PT

118 - Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate (PCS VI)
Speaker: Niazi, Tamim, MD - McGill University, Montreal, QC
3:10 PM - 3:20 PM PT

131 - Gut Microbiota Predictive of Consolidation Immunotherapy Efficacy and Toxicity after Chemoradiotherapy in Lung Cancer
Speaker: Li, Yitong, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing, Beijing
3:10 PM - 3:20 PM PT

138 - Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Underlies Immune Evasion after Radiotherapy
Speaker: Kong, Lingyi, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan, Hubei
3:12 PM - 3:19 PM PT

1039 - Integration of Imaging and Blood-Based Biomarkers for Prognostication in Locally Advanced Cervical Cancer
Speaker: Rajan, Shrikiriti, MD - University of Iowa, Iowa City, IA